Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Braz J Med Biol Res - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
Bivalirudin vs heparin in cardiac-cerebral ischemic and bleeding events among Chinese STEMI patients during percutaneous coronary intervention: a retrospective cohort study
Braz J Med Biol Res. 2023 Nov 13;56:e13013. doi: 10.1590/1414-431X2023e13013. eCollection 2023.ABSTRACTAlthough bivalirudin has been recently made available for purchase in China, large-scale analyses on the safety profile of bivalirudin among Chinese patients is lacking. Thus, this study aimed to compare the safety profile of bivalirudin and heparin as anticoagulants in Chinese ST-segment elevation myocardial infarction (STEMI) patients undergoing percutaneous coronary intervention (PCI). A total of 1063 STEMI patients undergoing PCI and receiving bivalirudin (n=424, bivalirudin group) or heparin (n=639, heparin group) as...
Source: Brazilian Journal of Medical and Biological Research - November 16, 2023 Category: Research Authors: Zhichao Bai Zhenzhen Wang Qiang Feng Yapei Zhang Mengying Zhang Aijun Hou Yiping Wu Zhenpeng Qin Lina Chai Source Type: research
